About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
European Journal of Cancer & Clinical Oncology
›
top-articles
European Journal of Cancer & Clinical Oncology
0.9
(top 50%)
impact factor
4.2K
(top 5%)
papers
65.6K
(top 5%)
citations
95
(top 5%)
h
-index
0.9
(top 50%)
impact factor
5.4K
all documents
66.5K
doc citations
145
(top 5%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
On the receiving end—patient perception of the side-effects of cancer chemotherapy
European Journal of Cancer & Clinical Oncology
1983
797
2
The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer
European Journal of Cancer & Clinical Oncology
1988
546
3
Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses
European Journal of Cancer & Clinical Oncology
1991
527
4
Breast conservation is the treatment of choice in small breast cancer: Long-term results of a randomized trial
European Journal of Cancer & Clinical Oncology
1990
444
5
Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions
European Journal of Cancer & Clinical Oncology
1982
424
6
Cancer in the European community and its member states
European Journal of Cancer & Clinical Oncology
1990
407
7
Comparison of the sulforhodamine B protein and tetrazolium (MTT) assays for in vitro chemosensitivity testing
European Journal of Cancer & Clinical Oncology
1991
387
8
Quadrantectomy versus lumpectomy for small size breast cancer
European Journal of Cancer & Clinical Oncology
1990
342
9
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD
European Journal of Cancer & Clinical Oncology
1985
336
10
Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: Long-term results
European Journal of Cancer & Clinical Oncology
1986
323
11
Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report
European Journal of Cancer & Clinical Oncology
1983
318
12
Isolation and characterization of DNA from the plasma of cancer patients
European Journal of Cancer & Clinical Oncology
1987
303
13
Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I)
European Journal of Cancer & Clinical Oncology
1990
281
14
Recombinant tumor necrosis factor: its effect and its synergism with interferon-γ on a variety of normal and transformed human cell lines
European Journal of Cancer & Clinical Oncology
1986
260
15
A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
European Journal of Cancer & Clinical Oncology
1991
251
16
Estrogen and antiestrogen binding sites in desmoid tumors
European Journal of Cancer & Clinical Oncology
1986
246
17
Aromatase, 17β-hydroxysteroid dehydrogenase and intratissular sex hormone concentrations in cancerous and normal glandular breast tissue in postmenopausal women
European Journal of Cancer & Clinical Oncology
1986
222
18
Clinical pharmacology of sodium butyrate in patients with acute leukemia
European Journal of Cancer & Clinical Oncology
1987
222
19
Cyclophosphamide versus ifosfamide: Final report of a randomized phase II trial in adult soft tissue sarcomas
European Journal of Cancer & Clinical Oncology
1987
217
20
Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A
European Journal of Cancer & Clinical Oncology
1991
193
21
Inoperable non-small cell lung cancer: Radiation with or without chemotherapy
European Journal of Cancer & Clinical Oncology
1988
190
22
Long-term survival in ovarian cancer
European Journal of Cancer & Clinical Oncology
1991
183
23
Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients
European Journal of Cancer & Clinical Oncology
1991
183
24
Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycle
European Journal of Cancer & Clinical Oncology
1983
181
25
Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-up
European Journal of Cancer & Clinical Oncology
1991
179
26
The treatment of adrenocortical carcinoma with o,p′-DDD: Prognostic simplications of serum level monitoring
European Journal of Cancer & Clinical Oncology
1984
176
27
Assessment of the quality of life of patients with advanced cancer
European Journal of Cancer & Clinical Oncology
1983
165
28
Human breast cancer in the athymic nude mouse: Cystostatic effects of long-term antiestrogen therapy
European Journal of Cancer & Clinical Oncology
1987
162
29
Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: Establishment, characterization and response to cytotoxic treatment
European Journal of Cancer & Clinical Oncology
1988
162
30
Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma
European Journal of Cancer & Clinical Oncology
1991
161
31
Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas
European Journal of Cancer & Clinical Oncology
1991
160
32
Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion
European Journal of Cancer & Clinical Oncology
1985
158
33
Characterization, toxicity and therapeutic efficacy of adrïamycin encapsulated in liposomes
European Journal of Cancer & Clinical Oncology
1982
157
34
Micrometastatic tumour cells in bone marrow of patients with gastric cancer: Methodological aspects of detection and prognostic significance
European Journal of Cancer & Clinical Oncology
1991
155
35
Methylprednisolone as palliative therapy for female terminal cancer patients
European Journal of Cancer & Clinical Oncology
1989
153
36
Primary extranodal and nodal non-Hodgkin's lymphoma
European Journal of Cancer & Clinical Oncology
1989
153
37
The epidemiology of ovarian cancer in Greece: A case-control study
European Journal of Cancer & Clinical Oncology
1984
151
38
Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: Evidence for a vascular mechanism
European Journal of Cancer & Clinical Oncology
1991
149
39
Respiratory tract tumours in hamsters exposed to acetaldehyde vapour alone or simultaneously to benzo(a)pyrene or diethylnitrosamine
European Journal of Cancer & Clinical Oncology
1982
146
40
Electrochemotherapy of spontaneous mammary tumours in mice
European Journal of Cancer & Clinical Oncology
1991
145
41
Testicular dysfunction in Hodgkin's disease before and after treatment
European Journal of Cancer & Clinical Oncology
1991
144
42
“Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer
European Journal of Cancer & Clinical Oncology
1991
144
43
Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy
European Journal of Cancer & Clinical Oncology
1987
142
44
Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programme
European Journal of Cancer & Clinical Oncology
1990
142
45
Human brain tumor xenografts in nude mice as a chemotherapy model
European Journal of Cancer & Clinical Oncology
1983
141
46
Novel growth regulatory factors and tumour angiogenesis
European Journal of Cancer & Clinical Oncology
1991
141
47
Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group
European Journal of Cancer & Clinical Oncology
1987
140
48
Cells secreting tumour necrosis factor show enhanced metastasis in nude mice
European Journal of Cancer & Clinical Oncology
1990
140
49
Neovascularization in human cutaneous melanoma: A quantitative morphological and Doppler ultrasound study
European Journal of Cancer & Clinical Oncology
1986
139
50
On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapy
European Journal of Cancer & Clinical Oncology
1983
138
site/software ©
exaly
; All materials licenced under
CC by-SA
.